Assessment of lisavanbulin (BAL101553) as an anti-lymphoma agent https://www.biorxiv.org/content/10.1101/2022.12.31.521730v1?med=mas
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.